Reappraising the role of class Ic antiarrhythmics in atrial fibrillation.
Dimitrios TsiachrisIoannis DoundoulakisPanagiotis TsioufisEirini PagkalidouChristos-Konstantinos AntoniouStefanos M ZafeiropoulosKonstantinos A GatzoulisKonstantinos TsioufisChristodoulos StefanadisPublished in: European journal of clinical pharmacology (2022)
Available in https://osf.io/apwt7/ , https://doi.org/10.17605/OSF.IO/APWT7.